核医学イメージング装置市場：製品、放射性医薬品、用途、エンドユーザー別-2025-2030年の世界予測

核医学イメージング装置市場の2024年の市場規模は59億5,000万米ドルで、2025年にはCAGR 5.94%で62億9,000万米ドルに成長し、2030年には84億1,000万米ドルに達すると予測されています。

核医学画像診断装置市場は、広範な診断技術展望の中で最もダイナミックな分野の一つとして浮上してきました。近年、技術の飛躍的な進歩により、画像診断装置の運用方法が再構築され、解像度の向上と手技効率の向上が組み合わされています。正確で非侵襲的な診断に対するニーズの高まりと相まって、急速な技術革新がこの市場を前進させています。新しい画像モダリティの導入と検出器技術の進歩は、臨床転帰の改善と患者管理の向上につながりました。利害関係者がこれらの進歩を活用し続けることで、この市場は世界中の医療システムにおいて診断プロトコルを再定義し、治療戦略を最適化する態勢を整えています。この分野での進化は、技術的なブレークスルーだけでなく、開業医や患者に対してより大きな価値を提供することにも注力している業界を浮き彫りにしています。本書では、市場変化の原動力、新たな動向、技術、規制、ヘルスケア需要の相互関係について包括的に考察します。

核医学イメージング装置市場の変革

核医学イメージングを取り巻く環境は、業界のパラダイムを根本的に変える変革期を迎えています。技術革新はこの進化の最前線にあり、画像解像度の向上、撮影時間の短縮、診断精度の向上が求められています。最近の進歩は、異なるモダリティを組み合わせたハイブリッドイメージングシステムを導入し、リアルタイムでの包括的な評価を可能にすることで、タイムリーで正確な治療計画の立案を可能にしています。規制機関もまた、新しい技術を統合するためにガイドラインを更新し、技術革新と産業界の協力を促す環境を醸成する役割を果たしてきました。最近の動向には、画像診断ワークフローを合理化し、画像解釈の精度を向上させる人工知能や機械学習の採用が増加していることが含まれます。こうしたシフトは業務効率を高めるだけでなく、個別化された治療レジメンを促進します。結局のところ、スマートテクノロジーと改良された画像診断装置の融合により、ヘルスケアプロバイダーはより的を絞った効果的な患者ケアを提供できるようになり、臨床現場における卓越した診断の新たな基準を設定しています。

核医学画像診断装置の主要セグメント分析

市場セグメンテーションを徹底的に分析することで、多様な製品カテゴリー、放射性医薬品、アプリケーション、エンドユーザープロファイルに関する洞察が明らかになります。まず製品セグメンテーションでは、平面シンチグラフィ・イメージング・システム、陽電子放出断層撮影（PET）スキャナー、単一光子放出コンピュータ断層撮影（SPECT）スキャナーで市場を評価します。SPECT分野では、ハイブリッドSPECTイメージング・システムとスタンドアロンSPECTイメージング・システムに分けられ、それぞれ独自の技術進歩を反映しています。放射性医薬品のセグメンテーションでは、フルオロデオキシグルコース（FDG）、ガリウム-68、ヨウ素-131、テクネチウム-99mなどの主要薬剤に焦点を当てた詳細なビューを提供し、これらの薬剤が診断精度に果たす重要な役割を強調しています。アプリケーション別のセグメンテーションでは、心臓病学、感染症診断、神経学、腫瘍学、整形外科などの分野についての洞察が得られ、複数の医療専門分野にわたる核医学イメージングの広範な有用性が示されています。さらに、エンドユーザーセグメンテーションは、画像診断センター、病院・診療所、研究機関からの多様な需要に光を当てています。このような多角的なセグメンテーションアプローチにより、市場力学、動向、成長機会の深い理解が容易になり、業界の進化に関する詳細な見通しが確実になります。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 新興国におけるヘルスケアインフラの拡大
    • 慢性疾患の増加と早期診断の需要の高まり
    • 核イメージングの調査開発を支援する政府の取り組みと資金
  • 抑制要因
    • 核イメージング装置の初期投資と運用コストの高さに伴うリスク
  • 機会
    • 診断能力を強化する画像ソリューションと人工知能の統合
    • 疾患の検出とモニタリングにおいて特異性と精度を提供する新しい放射性トレーサーの開発
  • 課題
    • 厳格な安全性と放射線コンプライアンス基準が核医学イメージング装置の生産を複雑化
• 市場セグメンテーション分析
  • 製品：強化された画像機能によりハイブリッドSPECT画像システムの需要が高まっています
  • 用途：心臓病の診断と管理における心臓学における核イメージング機器の好まれ方
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 核医学イメージング装置市場：製品別

• 平面シンチグラフィー画像システム
• 陽電子放出断層撮影（PET）スキャナー
• 単一光子放出コンピュータ断層撮影（SPECT）スキャナ
  • ハイブリッドSPECTイメージングシステム
  • スタンドアロンSPECTイメージングシステム

第7章 核医学イメージング装置市場放射性医薬品

• フルオロデオキシグルコース（FDG）
• ガリウム68
• ヨウ素131
• テクネチウム99m

第8章 核医学イメージング装置市場：用途別

• 心臓病学
• 感染症の診断
• 神経学
• 腫瘍学
• 整形外科

第9章 核医学イメージング装置市場：エンドユーザー別

• 診断画像センター
• 病院と診療所
• 調査機関

第10章 南北アメリカの核医学イメージング装置市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の核医学イメージング装置市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの核医学イメージング装置市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Absolute Imaging Inc.
• Advanced Accelerator Applications S.A. by Norvatis
• Agfa-Gevaert N.V
• Bayer AG
• Bozlu Holding A. S.
• Bracco Imaging S.p.A.
• Canon Medical Systems Corporation
• CMR Naviscan Corporation
• Cubresa Inc.
• DDD-Diagnostic A/S
• Digirad Corporation
• Edge Medical Solutions Private Limited
• GE HealthCare Technologies Inc.
• Koninklijke Philips N.V.
• Mediso Ltd.
• MR Solutions Ltd.
• Neusoft Medical Systems Co., Ltd.
• PerkinElmer Inc.
• Revvity Inc
• Rigaku Corporation
• Shimadzu Corporation
• Siemens AG
• Surgiceye GmbH
• United Imaging Healthcare Co., Ltd.

LIST OF FIGURES

• FIGURE 1. NUCLEAR IMAGING EQUIPMENT MARKET MULTI-CURRENCY
• FIGURE 2. NUCLEAR IMAGING EQUIPMENT MARKET MULTI-LANGUAGE
• FIGURE 3. NUCLEAR IMAGING EQUIPMENT MARKET RESEARCH PROCESS
• FIGURE 4. NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 17. AMERICAS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 19. UNITED STATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. NUCLEAR IMAGING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 25. NUCLEAR IMAGING EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. NUCLEAR IMAGING EQUIPMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NUCLEAR IMAGING EQUIPMENT MARKET DYNAMICS
• TABLE 7. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PLANAR SCINTIGRAPHY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET) SCANNERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY HYBRID SPECT IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY STANDALONE SPECT IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY FLUORODEOXYGLUCOSE (FDG), BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY GALLIUM-68, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY IODINE-131, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY TECHNETIUM-99M, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CANADA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. CANADA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 47. CANADA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 48. CANADA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CANADA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. CHINA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. CHINA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 74. CHINA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 75. CHINA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. CHINA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. INDIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. INDIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 79. INDIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 80. INDIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. INDIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. ITALY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. ITALY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 165. ITALY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 166. ITALY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. ITALY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. POLAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. POLAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 185. POLAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 186. POLAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. POLAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. QATAR NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. QATAR NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 190. QATAR NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 191. QATAR NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. QATAR NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SCANNERS, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 238. NUCLEAR IMAGING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 239. NUCLEAR IMAGING EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2024

The Nuclear Imaging Equipment Market was valued at USD 5.95 billion in 2024 and is projected to grow to USD 6.29 billion in 2025, with a CAGR of 5.94%, reaching USD 8.41 billion by 2030.

The nuclear imaging equipment market has emerged as one of the most dynamic sectors in the broader diagnostic technology landscape. In recent years, significant strides in technology have reshaped the way imaging equipment operates, combining enhanced resolution with increased procedural efficiency. Rapid innovation, paired with the growing need for accurate and non-invasive diagnostics, has propelled this market forward. The introduction of new imaging modalities and advances in detector technology have translated into better clinical outcomes and improved patient management. As stakeholders continue to leverage these advancements, the market stands poised to redefine diagnostic protocols and optimize therapeutic strategies in health care systems worldwide. The evolution within this field highlights an industry that is not only focused on technological breakthroughs but also on delivering greater value to practitioners and patients alike. This document provides a comprehensive look into the driving factors behind market changes, emerging trends, and the interplay between technology, regulation, and healthcare demands.

Transformative Shifts in the Nuclear Imaging Landscape

The nuclear imaging landscape is undergoing transformative shifts that are fundamentally altering industry paradigms. Technological innovations are at the forefront of this evolution, driven by the need for higher image resolution, faster acquisition times, and enhanced diagnostic accuracy. Recent advancements have introduced hybrid imaging systems that combine different modalities, allowing for comprehensive assessments in real-time, thereby ensuring timely and precise treatment planning. Regulatory bodies have also played a role by updating guidelines to integrate novel technologies, thereby fostering an environment that encourages innovation and industry collaboration. Recent trends include the increasing adoption of artificial intelligence and machine learning, which streamline imaging workflows and improve the precision of image interpretation. These shifts are not only enhancing operational efficiency but also facilitating personalized treatment regimens. Ultimately, the convergence of smart technologies with improved imaging equipment is empowering healthcare providers to deliver more targeted and effective patient care, setting a new standard for diagnostic excellence in clinical settings.

Key Segmentation Insights in Nuclear Imaging Equipment

A thorough analysis of market segmentation reveals insights into diverse product categories, radiopharmaceuticals, applications, and end-user profiles. Beginning with the product segmentation, the market is evaluated across Planar Scintigraphy Imaging Systems, Positron Emission Tomography (PET) Scanners, and Single Photon Emission Computed Tomography (SPECT) Scanners. Within the SPECT segment, the division extends further into Hybrid SPECT Imaging Systems and Standalone SPECT Imaging Systems, each reflecting unique technological advancements. Radiopharmaceutical segmentation offers a detailed view with a focus on key agents such as Fluorodeoxyglucose (FDG), Gallium-68, Iodine-131, and Technetium-99m, underscoring the critical role these agents play in diagnostic accuracy. The application-based segmentation provides insights into areas like Cardiology, Infectious Disease Diagnosis, Neurology, Oncology, and Orthopedics, illustrating the expansive utility of nuclear imaging across multiple medical specialties. Additionally, the end-user segmentation sheds light on the varied demands coming from Diagnostic Imaging Centers, Hospitals & Clinics, and Research Institutes. This multi-dimensional segmentation approach facilitates a deeper understanding of market dynamics, trends, and growth opportunities, ensuring a detailed perspective on industry evolution.

Based on Product, market is studied across Planar Scintigraphy Imaging Systems, Positron Emission Tomography (PET) Scanners, and Single Photon Emission Computed Tomography (SPECT) Scanners. The Single Photon Emission Computed Tomography (SPECT) Scanners is further studied across Hybrid SPECT Imaging Systems and Standalone SPECT Imaging Systems.

Based on Radiopharmaceuticals, market is studied across Fluorodeoxyglucose (FDG), Gallium-68, Iodine-131, and Technetium-99m.

Based on Application, market is studied across Cardiology, Infectious Disease Diagnosis, Neurology, Oncology, and Orthopedics.

Based on End-User, market is studied across Diagnostic Imaging Centers, Hospitals & Clinics, and Research Institutes.

Regional Insights Across Key Markets

The geographical distribution of the nuclear imaging equipment market offers a rich perspective on regional demand and growth trajectories. In the Americas, technological adoption is high, and clinical practices are rapidly embracing advanced imaging solutions to enhance diagnostic precision, driven by both well-established healthcare infrastructure and progressive research initiatives. The region comprising Europe, the Middle East, and Africa demonstrates a balanced mix of mature markets and emerging economies, with steady investments in technology modernization and regulatory frameworks that support innovation in nuclear imaging. Meanwhile, the Asia-Pacific region showcases robust growth potential, bolstered by rising healthcare expenditures, an expanding network of state-of-the-art diagnostic centers, and government-led initiatives aimed at improving overall healthcare quality. This regional analysis underscores the importance of tailored strategies that consider distinct market needs, regulatory harmonization, and technological adoption rates across various geographies. The dynamic interplay of these global regions contributes to a vibrant and evolving marketplace, where sustained growth and innovation are well within reach.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape and Key Company Insights

The competitive landscape of the nuclear imaging equipment market is shaped by several prominent companies that drive technology, innovation, and clinical application. Leading entities such as Absolute Imaging Inc. and Advanced Accelerator Applications S.A. by Norvatis have made significant inroads by continuously developing state-of-the-art imaging systems. Companies like Agfa-Gevaert N.V and Bayer AG contribute to the broad spectrum of imaging solutions by focusing on precision, reliability, and integration with existing diagnostic protocols. Additionally, players such as Bozlu Holding A. S., Bracco Imaging S.p.A., and Canon Medical Systems Corporation emphasize both advanced imaging technology and comprehensive service offerings. Notably, contributions from CMR Naviscan Corporation, Cubresa Inc., and DDD-Diagnostic A/S further galvanize market innovation with specialized imaging instruments. The dominance of global leaders including Digirad Corporation, Edge Medical Solutions Private Limited, GE HealthCare Technologies Inc., and Koninklijke Philips N.V. is evident when their technological solutions are combined with robust service networks. Leading firms such as Mediso Ltd., MR Solutions Ltd., Neusoft Medical Systems Co., Ltd., PerkinElmer Inc., Revvity Inc, Rigaku Corporation, Shimadzu Corporation, Siemens AG, Surgiceye GmbH, and United Imaging Healthcare Co., Ltd. complete the competitive spectrum by offering diversified products and exemplifying best practices in clinical diagnostics. This competitive mix not only fosters healthy market dynamics but also propels ongoing advancements and collaborative efforts in the industry.

The report delves into recent significant developments in the Nuclear Imaging Equipment Market, highlighting leading vendors and their innovative profiles. These include Absolute Imaging Inc., Advanced Accelerator Applications S.A. by Norvatis, Agfa-Gevaert N.V, Bayer AG, Bozlu Holding A. S., Bracco Imaging S.p.A., Canon Medical Systems Corporation, CMR Naviscan Corporation, Cubresa Inc., DDD-Diagnostic A/S, Digirad Corporation, Edge Medical Solutions Private Limited, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Mediso Ltd., MR Solutions Ltd., Neusoft Medical Systems Co., Ltd., PerkinElmer Inc., Revvity Inc, Rigaku Corporation, Shimadzu Corporation, Siemens AG, Surgiceye GmbH, and United Imaging Healthcare Co., Ltd.. Actionable Recommendations for Industry Leaders

Industry leaders should focus on integrating advanced imaging modalities with emerging data analytics to drive innovation and clinical value. It is essential for decision-makers to invest in research and development initiatives that foster the convergence of artificial intelligence with nuclear imaging technologies, thereby optimizing diagnostic precision and workflow efficiency. Stakeholders must also establish strategic partnerships with technology innovators to expedite the translation of clinical research into practice. Embracing customized product offerings that cater to the unique needs of various end-user segments can create a competitive advantage and promote market expansion. Leaders are encouraged to enhance regulatory compliance mechanisms that align with international standards and accelerate market entry across diverse geographies. Moreover, investing in workforce training programs to ensure the proficient use of new imaging technologies will further solidify market leadership. By developing a robust supply chain and prioritizing data security in digital imaging systems, companies can build resilience in volatile markets. Together, these strategic recommendations can serve as the cornerstone for sustainable growth, technological advancement, and improved patient care within the nuclear imaging domain.

Conclusion and Key Takeaways

The evolving landscape of the nuclear imaging equipment market underscores significant technological innovations, market segmentation intricacies, regional dynamics, and the competitive rigor that defines this sector today. The comprehensive analysis presented in this report illustrates how advancements in imaging techniques and a tailored approach to market segmentation are reshaping clinical practices. Industry stakeholders are now better positioned to address the complexities of modern diagnostics through versatile product offerings, strategic investments in research and development, and enhanced regulatory adherence. The global uptake of hybrid imaging systems, coupled with the rise of decentralized healthcare services, heralds a future marked by improved diagnostic accuracy and patient-centric care. As technological integration continues to advance and competitive dynamics evolve, decision-makers must leverage these insights to foster growth, innovation, and operational excellence. The conclusions drawn here present a roadmap for industry success that is both timely and indispensable for navigating the challenges and opportunities ahead.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Expansion of the healthcare infrastructure in the emerging economies
    • 5.1.1.2. Increasing prevalence of chronic diseases and the growing demand for early diagnosis
    • 5.1.1.3. Government initiatives and funding to support nuclear imaging research and developments
  • 5.1.2. Restraints
    • 5.1.2.1. Risks associated with high initial investment and operational costs of nuclear imaging equipments
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of artificial intelligence with imaging solutions enhancing diagnostic capabilities
    • 5.1.3.2. Development of novel radiotracers that offer specificity and accuracy in disease detection and monitoring
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent safety and radiation compliance standards complicating nuclear imaging equipment production
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Rising demand for hybrid SPECT imaging systems owing to the enhanced imaging capabilities
  • 5.2.2. Application: Growing preference for nuclear imaging equipments in cardiology for diagnosing and managing heart diseases
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Nuclear Imaging Equipment Market, by Product

• 6.1. Introduction
• 6.2. Planar Scintigraphy Imaging Systems
• 6.3. Positron Emission Tomography (PET) Scanners
• 6.4. Single Photon Emission Computed Tomography (SPECT) Scanners
  • 6.4.1. Hybrid SPECT Imaging Systems
  • 6.4.2. Standalone SPECT Imaging Systems

7. Nuclear Imaging Equipment Market, by Radiopharmaceuticals

• 7.1. Introduction
• 7.2. Fluorodeoxyglucose (FDG)
• 7.3. Gallium-68
• 7.4. Iodine-131
• 7.5. Technetium-99m

8. Nuclear Imaging Equipment Market, by Application

• 8.1. Introduction
• 8.2. Cardiology
• 8.3. Infectious Disease Diagnosis
• 8.4. Neurology
• 8.5. Oncology
• 8.6. Orthopedics

9. Nuclear Imaging Equipment Market, by End-User

• 9.1. Introduction
• 9.2. Diagnostic Imaging Centers
• 9.3. Hospitals & Clinics
• 9.4. Research Institutes

10. Americas Nuclear Imaging Equipment Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Nuclear Imaging Equipment Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Nuclear Imaging Equipment Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. FPNV Positioning Matrix, 2024
• 13.3. Competitive Scenario Analysis
  • 13.3.1. GE HealthCare's AI-driven innovations at RSNA 2024 to enhance radiology precision and efficiency
  • 13.3.2. Innovative partnership between Jubilant Radiopharma and Simplified Imaging revolutionizes cost-efficient nuclear medicine services in the U.S.
  • 13.3.3. Spectrum Dynamics enhancement with installation of the VERITON-CT SPECT/CT imaging system
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Absolute Imaging Inc.
• 2. Advanced Accelerator Applications S.A. by Norvatis
• 3. Agfa-Gevaert N.V
• 4. Bayer AG
• 5. Bozlu Holding A. S.
• 6. Bracco Imaging S.p.A.
• 7. Canon Medical Systems Corporation
• 8. CMR Naviscan Corporation
• 9. Cubresa Inc.
• 10. DDD-Diagnostic A/S
• 11. Digirad Corporation
• 12. Edge Medical Solutions Private Limited
• 13. GE HealthCare Technologies Inc.
• 14. Koninklijke Philips N.V.
• 15. Mediso Ltd.
• 16. MR Solutions Ltd.
• 17. Neusoft Medical Systems Co., Ltd.
• 18. PerkinElmer Inc.
• 19. Revvity Inc
• 20. Rigaku Corporation
• 21. Shimadzu Corporation
• 22. Siemens AG
• 23. Surgiceye GmbH
• 24. United Imaging Healthcare Co., Ltd.